Reporters tweets about ‘vague whispers’ of bid interest in TG Therapeutics
Dominic Walsh, a business reporter who previously covered the leisure and drinks industry for The Times from 1997 to 2024, stated in post to X: ...
Yahoo Finance2d
TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance
NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the third quarter of 2024, along with recent ...
Seeking Alpha2d
AbbVie: Emraclidine's Failure Eliminates An Important Growth Driver
Analyst’s Disclosure: I/we have a beneficial long position in the shares of NBIX either through stock ownership, options, or ...
HC Wainwright Forecasts Strong Price Appreciation for TG Therapeutics (NASDAQ:TGTX) Stock
TG Therapeutics (NASDAQ:TGTX – Free Report) had its target price increased by HC Wainwright from $49.00 to $55.00 in a report ...
bovnews5d
TG Therapeutics Inc common stock (TGTX) Stock Trading Recap
On Friday, TG Therapeutics Inc common stock (TGTX) stock saw a modest uptick, ending the day at $28.81 which represents a slight increase of $0.91 or 3.26% from the prior close of $27.9. The stock ...
TG Therapeutics, Inc. Just Missed Earnings - But Analysts Have Updated Their Models
It's been a good week for TG Therapeutics, Inc. ( NASDAQ:TGTX ) shareholders, because the company has just released ...